Ixiaro Suspension For Injection 6Mcg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Ixiaro: Suspension for injection (6mcg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

JAPANESE ENCEPHALITIS VIRUS VACCINE (jap uh NEEZ en sef uh LAHY tis VAHY ruhs vak SEEN) is a vaccine. It is used to help prevent Japanese encephalitis infections. You cannot get the disease from the vaccine.

In-Depth Information

Ixiaro Vaccine Suspension for Injection

NDC: 425150001
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Japanese Encephalitis Prophylaxis

Storage Information
Refrigerate (between 36 and 46 degrees F)
Store in original package until time of use
Do not freeze
Ixiaro Vaccine Suspension for Injection

Reported Side Effects for Ixiaro Vaccine Suspension for Injection

Cough Incidence:
1.2%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
1.3%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
1.3%*
Severity: MILD
Onset: DELAYED
Rhinitis Incidence:
1.4%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
1.4%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
1.5%*
Severity: MILD
Onset: EARLY
Infection Incidence:
1.7%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
3.2%*
Severity: MILD
Onset: EARLY
Itching Incidence:
3.8%*
Severity: MILD
Onset: RAPID
Swelling Incidence:
4.2%*
Severity: MODERATE
Onset: DELAYED
Sore Throat Incidence:
4.7%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
6.6%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
9.6%*
Severity: MODERATE
Onset: EARLY
Tired Incidence:
11.3%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
15.6%*
Severity: MILD
Onset: EARLY
Headache Incidence:
27.9%*
Severity: MILD
Onset: EARLY
Injection Site Reaction Incidence:
32.6-48.5%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ixiaro

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5